Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Nicholas Figura"'
Autor:
Emily Keit MD, Casey Liveringhouse MD, Nicholas Figura MD, Joseph Weygand PhD, Maria L. Sandoval MD, Genevieve Garcia CMD, Julia Peters CMD, Michael Nieder MD, Rawan Faramand MD, Farhad Khimani MD, Sungjune Kim MD, PhD, Timothy J. Robinson MD, PhD, Peter A.S. Johnstone MD, Jose Penagaricano MD, Kujtim Latifi PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Introduction: High-dose total body irradiation (TBI) is often part of myeloablative conditioning in acute leukemia. Modern volumetric modulated arc therapy (VMAT)-based plans employ arcs to the inferior-most portion of the body that can be simulated
Externí odkaz:
https://doaj.org/article/b4ea26ac7d884ff3a7e48f8c1c2c5dd2
Publikováno v:
Hematology/Oncology Clinics of North America. 32:447-458
Metastatic bone pain is a complex, poorly understood process. Understanding the unique mechanisms causing cancer-induced bone pain may lead to potential therapeutic targets. This article discusses the effects of osteoclast overstimulation within the
Autor:
Roberto J. Diaz, Chetna Thawani, Michael A. Vogelbaum, Timothy J. Robinson, Kamran Ahmed, Nicholas Figura, Iman R. Washington, Matthew N. Mills, Hsiang-Hsuan Yu, S. Sarangkasiri, Arnold B. Etame
Publikováno v:
Neuro Oncol
BACKGROUND Management of breast cancer brain metastases has become an increasing concern due to improved systemic control. Failure patterns in the brain may vary by breast cancer subtype. OBJECTIVE In this study, we sought to distinguish our institut
Clinical Outcomes of Breast Brain Metastases by Subtype following LINAC Based Stereotactic Radiation
Autor:
Kamran Ahmed, S. Sarangkasiri, Hsiang-Hsuan Michael Yu, Arnold B. Etame, Matthew N. Mills, Timothy J. Robinson, Michael A. Vogelbaum, Iman R. Washington, Roberto J. Diaz, Chetna Thawani, Nicholas Figura
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:E18-E19
Autor:
Evan Wuthrick, Kamran Ahmed, Louis B. Harrison, Bradford A. Perez, Daniel E. Oliver, Javier F. Torres-Roca, Kosj Yamoah, Homan Mohammadi, Nicholas Figura, Jimmy J. Caudell, A.O. Naghavi, J.M. Frakes
Publikováno v:
Seminars in radiation oncology. 29(2)
Current standard radiotherapy doses have been derived from empiric methods rather than a scientific framework. Subclinical nodal dosing remains relatively uniform across most disease sites, despite heterogeneity in patient and tumor biology. It is no
Autor:
Julio C. Chavez, Daniel E. Oliver, Timothy J. Robinson, Nicholas Figura, Madeline Hooper, Catherine Doyle, Matthew N. Mills, George P. Yang, Sungjune Kim
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:E15
Autor:
Austin J. Sim, Aleksandr Lazaryan, Farhad Khimani, Bijal D. Shah, Nicholas Figura, Timothy J. Robinson, Marco L. Davila, Michael D. Jain, Sungjune Kim, Frederick L. Locke, Julio C. Chavez
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:E51
Autor:
Kamran Ahmed, Russel Palm, Arnold B. Etame, Nicholas Figura, Daniel E. Oliver, Timothy J. Robinson, Michael Yu, James K. Liu, Jeffrey Peacock, Austin J. Sim, Homan Mohammadi, Aaron Tolpin, Michael A. Vogelbaum, Nam D. Tran
Publikováno v:
Neuro Oncol
Metastases (BM) carries the risk of hemorrhaging lesions and can be effectively treated using stereotactic radiotherapy (SRT). Nivolumab is a recently approved immunotherapy for stage IV RCC. We evaluate whether patients with RCC BM treated with SRT
Autor:
Neha Patel, Tobin Strom, Nikhil G. Rao, S. Sarangkasiri, Arnold B. Etame, Kujtim Latifi, Tzu-Hua Juan, Prakash Chinnaiyan, Jessica M. Frakes, Kamran Ahmed, Nicholas Figura
Publikováno v:
Journal of Neurosurgery. 123:1261-1267
OBJECT Linear accelerator (LINAC)-based stereotactic radiosurgery (SRS) is a treatment option for patients with melanoma in whom brain metastases have developed. Very limited data are available on treating patients with ≥ 5 lesions. The authors sou
Autor:
Tobin Strom, Kevin Nethers, Alex Cruz, Daniel C. Fernandez, Randy V. Heysek, Richard B. Wilder, Eric A. Mellon, Dylan Hunt, Nicholas Figura, Amarjit S. Saini, Kushagra Shrinath
Publikováno v:
Brachytherapy. 14:818-825
Purpose To compare urinary, bowel, and sexual health-related quality-of-life (HRQOL) changes due to high-dose-rate (HDR) brachytherapy, low-dose-rate (LDR) brachytherapy, or intensity-modulated radiation therapy (IMRT) monotherapy for prostate cancer